Screen of more than 2,400 microRNAs identifies multiple candidates that significantly enhance vector productivity without compromising quality attributes. Munich, Germany – November 5, 2025 – Ascend Advanced Therapies scientists have published a study in New Biotechnology identifying microRNAs (miRNAs) that improve recombinant adeno-associated virus (rAAV) production in HEK293 cells. The paper, titled “A human genome-wide Read More The post Ascend Advanced Therapies Identifies microRNAs That Enhance AAV Vector Production appeared first on Ascend .